A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

Status:
Completed

Trial end date:
2021-04-21

Target enrollment:

Participant gender:

The purpose of this study to evaluate the efficacy of SAGE-217 in the treatment of participants with MDD.

Phase 3

Sage Therapeutics